AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
The right genes may amplify hormone replacement therapy's ability to boost MDL cholesterol levels and could give some postmenopausal women an edge in the fight against heart disease, reported Dr. David M. Herrington and associates at Wake Forest University; Winston-Salem, N.C.
The finding could pave the way for genetic testing that better predicts HRT's effects on a woman's cardiovascular health.
The investigators measured the relationship between 10 variations of the estrogen receptor-[alpha] gene (ER-a) and the effect of HRT on MDL cholesterol levels. The researchers randomly assigned 309 postmenopausal women with established coronary artery disease to daily treatment with either 0.625 mg of estrogen, 0.625 mg of estrogen and 2.5 mg of progestin, or a placebo. The women were followed for an average of 3.2 years (N. Engl. J. Med. 346[13]:967-74, 2002).
Women with a relatively rare variation in their ER-a gene (only 18.9% of women) showed up to a 33% increase in [HDL.sub.3] cholesterol levels when treated with HRT That ...